FX (foreign exchange) effects colour US firms' performance in latest quarter
This article was originally published in Clinica
Amersham's sales of equipment for diagnostics helped prop up ailing revenues from laboratory equipment in the first quarter of 2003. However, the UK-based company suffered from unfavourable foreign exchange (FX) rates. Excluding the effects of this, and of discontinued product lines, sales were up by 6%. In April the company merged its non-core brachytherapy business with US firm Galil Medical's urology business, to sharpen its own focus on medical diagnostics.